Harrell, F.E.

patient survival cost-effectiveness treatment streptokinase analysis ratio cost-effectiveness ratio t-pa group infarction group fi rst year percent life expectancy gusto gusto study study value hospital england journal expectancy thrombolytic 100 patients medicine increase university cost-effectiveness ratios health therapy stroke tissue plasminogen activator medicine downloaded t-pa treatment erasmus university difference follow-up curve treatment groups 30- day mortality catheterization journal thrombolytic therapy england cost differences hospitalization analyses sensitivity model cost effectiveness effectiveness department physician table cost-effectiveness value society survival curves dollar 21 cost effectiveness estimate resource mortality medicare fee schedule month disease agent thrombolytic agents 5 percent costeffectiveness ratio erasmu basis 6 months state subgroup subgroups price 2011. cardiology assumption quality nejm.org